Construction of anticancer drug incorporated aptamer-functionalized cationic β-lactoglobulin: induction of cell cycle arrest and apoptosis in colorectal cancer DOI
Zhipeng Zhang, Tianran Zhang, Zimeng Li

и другие.

Journal of Biomaterials Science Polymer Edition, Год журнала: 2024, Номер unknown, С. 1 - 20

Опубликована: Окт. 16, 2024

Nanoscale drug delivery systems that are both multifunctional and targeted have been developed using proteins as a basis, thanks to their attractive biomacromolecule properties. A novel nanocarrier, aptamer (AS1411)-conjugated β-lactoglobulin/poly-l-lysine (BLG/Ap/PL) nanoparticles, was in this study. To unique formulation, the as-prepared nanocarrier blends distinctive features of an chemotherapeutic targeting agent with those protein nanocarriers. By loading cabazitaxel (CTX) onto nanocarriers, therapeutic potential BLG/Ap/PL could be demonstrated. The CTX-loaded (CTX@BLG/Ap/PL) showed regulated release profile acidic milieu, which improve efficacy cancer cells high encapsulation up 93%. However, compared free CTX, CTX@BLG/Ap/PL killed colorectal HCT116 higher at 24 48 h. Further investigation confirms apoptosis by acridine orange ethidium bromide (AO/EB), DAPI staining morphological changes, chromatin condensation, membrane blebbing treated cell through flow cytometry displayed percentages apoptosis. Cell cycle analysis revealed induced sub-G1 G2/M phase (apoptosis) Annexin V/propidium iodide (PI) confirmed induces cells. Overall, study proved had several advantages over drugs promise solution clinical problems associated antitumor systems.

Язык: Английский

Bio synthesis, comprehensive characterization, and multifaceted therapeutic applications of BSA-Resveratrol coated platinum nanoparticles DOI Creative Commons
Shah Faisal, Muhammad Hamza Tariq,

Abdullah Abdullah

и другие.

Scientific Reports, Год журнала: 2024, Номер 14(1)

Опубликована: Апрель 3, 2024

This study examines the manufacturing, characterization, and biological evaluation of platinum nanoparticles, which were synthesized by Enterobacter cloacae coated with Bovine Serum Albumin (BSA) Resveratrol (RSV). The formation PtNPs was confirmed change color from dark yellow to black, due bioreduction chloride E. cloacae. BSA RSV functionalization enhanced these nanoparticles' biocompatibility therapeutic potential. TGA, SEM, XRD, FTIR employed for where drug conjugation-related functional groups studied FTIR. XRD crystalline nature Pt-BSA-RSV NPs, while TGA SEM showed thermal stability post-drug coating morphological changes. Designed composite also found be biocompatible in hemolytic testing, indicating their potential Biomedical applications. After confirmation based nanocaompsite synthesis, they examined anti-bacterial, anti-oxidant, anti-inflammatory, anti-cancer properties. NPs higher concentration-dependent DPPH scavenging activity, measured antioxidant capability. Enzyme inhibition tests demonstrated considerable anti-inflammatory activity against COX-2 15-LOX enzymes. In vitro anticancer studies, effectively killed human ovarian cancer cells. phenomenon facilitated acidic environment cancer, as release assay NP formulation environment. Finally, Molecular docking that has strong an antibacterial, agent. Overall, silico investigations current good medicinal applications designed nanocomposites, however, further in-vivo experiments must conducted validate our findings.

Язык: Английский

Процитировано

19

Novel epirubicin-loaded nanoformulations: Advancements in polymeric nanocarriers for efficient targeted cellular and subcellular anticancer drug delivery DOI
Mehrab Pourmadadi, Shima Ostovar, Gustavo Ruiz-Pulido

и другие.

Inorganic Chemistry Communications, Год журнала: 2023, Номер 155, С. 110999 - 110999

Опубликована: Июнь 29, 2023

Язык: Английский

Процитировано

38

Polymeric nanoparticles as delivery vehicles for targeted delivery of chemotherapy drug fludarabine to treat hematological cancers DOI

Mehrab Pourmadadi,

Hamed Mirzaei Dehaghi,

Amirhossein Ghaemi

и другие.

Inorganic Chemistry Communications, Год журнала: 2024, Номер 167, С. 112819 - 112819

Опубликована: Июль 6, 2024

Язык: Английский

Процитировано

11

Inhalable Nano Formulation of Cabazitaxel: A Comparative Study with Intravenous Route DOI Creative Commons
Elif Kağa, Sadık Kağa,

Korhan Altunbas

и другие.

Macromolecular Bioscience, Год журнала: 2025, Номер unknown

Опубликована: Янв. 30, 2025

Abstract Chemotherapy is generally given by intravenous (IV) administration which provides higher bioavailability than other systemic routes. However, in the case of lung cancer, pulmonary (INH) route choice for inhalable formulations. In study, biochemical and histological parameters Cabazitaxel (CBZ) free (2 mg kg −1 ) nanoparticle (NP) CBZ equivalent) formulations are investigated after IV INH rats. The nanoformulation obtained using PEGylated polystyrene (PEG‐PST) nanoparticles PISA. While a nose head‐only device used administration, jugular vein as route. Blood samples (blank, 24 h, 48 h) collected via carotid artery cannulas without handling metabolism cages. According to parameters, formulation applied or shows toxicity. On hand, showed no signs toxicity both Higher longer retention observed inhaled nanoformulation. Histological analysis alveolar macrophage migration due enhanced retention. Results that nanotechnology defense system gave advantage end up with an nanomedicine cancer.

Язык: Английский

Процитировано

1

Targeted Nano-Delivery of Flutamide with polymeric and lipid nanoparticles DOI
Amirhossein Ghaemi,

Amirhossein Khanizadeh,

Mehrab Pourmadadi

и другие.

European Polymer Journal, Год журнала: 2024, Номер 213, С. 113124 - 113124

Опубликована: Май 16, 2024

Язык: Английский

Процитировано

7

Advancing cancer therapy: Unveiling the cutting-edge potential of carmustine nano carriers for targeted treatment DOI

Amirhossein Khanizadeh,

Amirhossein Ghaemi, Mehrab Pourmadadi

и другие.

Journal of Drug Delivery Science and Technology, Год журнала: 2024, Номер 99, С. 105943 - 105943

Опубликована: Июль 4, 2024

Язык: Английский

Процитировано

6

Nanotechnology-based drug delivery for breast cancer treatment: Current applications and future directions DOI Creative Commons
Md Abdus Samad, Iftikhar Ahmad, Torki A. Zughaibi

и другие.

European Journal of Medicinal Chemistry Reports, Год журнала: 2025, Номер unknown, С. 100268 - 100268

Опубликована: Апрель 1, 2025

Язык: Английский

Процитировано

0

Engineering of Dual-drug Delivery of Oxaliplatin and Cabazitaxel Using Chitosan-PNIPAM Clacked Metal-organic Frameworks: A Path to Precision of pH/thermo Responsive Tactic to Liver cancer DOI

Conghuan Shen,

Jianhua Li,

Quanbao Zhang

и другие.

Journal of Polymers and the Environment, Год журнала: 2025, Номер unknown

Опубликована: Фев. 21, 2025

Язык: Английский

Процитировано

0

In vitro anticancer activity of encapsulated polymeric nanoparticles of cabazitaxel and ruthenium compound NAMI-A drugs in the treatment of esophogeal cancer DOI

Jiani Zhang,

Xiaoli Mei,

Erliang Zheng

и другие.

Journal of materials research/Pratt's guide to venture capital sources, Год журнала: 2025, Номер unknown

Опубликована: Март 10, 2025

Язык: Английский

Процитировано

0

Preclinical Efficacy of Cabazitaxel Loaded Poly(2-alkyl cyanoacrylate) Nanoparticle Variants DOI Creative Commons
Remya Valsalakumari, Abhilash Pandya, Lina Prasmickaite

и другие.

International Journal of Nanomedicine, Год журнала: 2024, Номер Volume 19, С. 3009 - 3029

Опубликована: Март 1, 2024

Background: Biodegradable poly(alkyl cyanoacrylate) (PACA) nanoparticles (NPs) are receiving increasing attention in anti-cancer nanomedicine development not only for targeted cancer chemotherapy, but also modulation of the tumor microenvironment. We previously reported promising results with cabazitaxel (CBZ) loaded poly(2-ethylbutyl NPs (PEBCA-CBZ NPs) a patient derived xenograft (PDX) model triple-negative breast cancer, and this was associated decrease M2 macrophages. The present study aims at comparing two endotoxin-free PACA NP variants (PEBCA poly(2-ethylhexyl cyanoacrylate); PEHCA), CBZ test whether conjugation folate would improve their effect. Methods: Cytotoxicity assays cellular uptake by flow cytometry were performed different cells. Biodistribution efficacy studies PDX models cancer. Tumor immune cells analyzed multiparametric cytometry. Results: In vitro showed similar NP-induced cytotoxicity patterns despite difference early internalization. On intravenous injection, liver cleared majority NPs. Efficacy HBCx39 demonstrated an enhanced effect drug-loaded PEBCA compared free drug PEHCA Furthermore, conjugated variant did show any effects unconjugated counterpart which might be due to unfavorable orientation on Finally, analyses cell populations tumors revealed that treatment affected myeloid cells, especially macrophages, contributing inflammatory, activated Conclusion: report first time, comparative triple negative CBZ-loaded exhibit combined compartment, may boost anti-tumor response. Keywords: cyanoacrylate), cabazitaxel, patient-derived xenograft, microenvironment

Язык: Английский

Процитировано

2